NRXP — NRX Pharmaceuticals, Inc.

Why people talked about NRXP (2026-10-30)

• NRx Pharmaceuticals is scheduled to host a conference call on October 30 at 8:30 AM ET regarding a regulatory milestone for its Preservative-Free Ketamine program.
• A press release is expected to be issued before the market open on October 30 to discuss the regulatory milestone and next steps for commercialization.
• The company previously announced that the ANDA for KETAFREE was approved by the FDA, with a goal date of November 10.